Results 71 to 80 of about 6,382 (203)
Biomedical Chromatography, Volume 40, Issue 5, May 2026.ABSTRACT A precise, robust, and stability‐indicating liquid chromatographic (LC) method coupled with a photodiode array (PDA) detector was developed and validated for the quantitative estimation of rifapentine, an essential therapeutic agent for both active and latent tuberculosis (TB).
Siva Prasad Korikana +5 more
wiley +1 more source
Epidemiology and genetic characteristics of Clostridioides difficile isolates in Northwest China [PDF]
PeerJClostridioides difficile (C. difficile) is a significant hospital-acquired pathogen that can cause antibiotic-associated diarrhea. In this study, we investigate the epidemiological and genetic characteristics of C.
Yang Li +5 more
doaj +2 more sources
IDCases, 2019 We report a case of concurrent development of active pulmonary tuberculosis and invasive pulmonary aspergillosis (IPA) in a patient who received therapy with infliximab for Crohn’s disease.
Antonio Riccardo Buonomo +9 more
doaj +1 more source
Antibiotics, 2019 Neutrophils are important assets in defense against invading bacteria like staphylococci. However, (dysfunctioning) neutrophils can also serve as reservoir for pathogens that are able to survive inside the cellular environment. Staphylococcus aureus is a
Suzanne Bongers +4 more
doaj +1 more source
Biosynthesis of Rifamycine [PDF]
Pathologia et Microbiologia, 2008 M, Liersch +3 more
openaire +2 more sources
Rifamycins, Alone and in Combination [PDF]
Cold Spring Harbor Perspectives in Medicine, 2016 Rifamycins inhibit RNA polymerase of most bacterial genera. Rifampicin remains part of combination therapy for treating tuberculosis (TB), and for treating Gram-positive prosthetic joint and valve infections, in which biofilms are prominent. Rifabutin has use for AIDS patients in treating mycobacterial infections TB and Mycobacterium avium complex (MAC)
openaire +2 more sources
Synthesis of Nucleosidyl Rifamycins as Inhibitors of Human Immunodeficiency Virus Type 1 [PDF]
, 1997 In the search for potential nucleoside/non-nucleoside mixed type inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase, we synthesized a new set of rifamycin S derivatives, containing AZT connected via its hydroxyl at 5' C ...
A. DI CARO +10 more
core
Divergent Rifamycin Susceptibilities of Clostridium difficile Strains in Canada and Italy and Predictive Accuracy of Rifampin Etest for Rifamycin Resistance [PDF]
, 2011 We tested the activities of rifampin (RIF) and rifaximin (RFX) against 180 Clostridium difficile clinical isolates selected from Canadian and Italian culture collections.
Mark A. Miller +4 more
core +1 more source
Expeditious asymmetric synthesis of a stereoheptad corresponding to the C(19)-C(27)-ansa chain of rifamycins: Formal total synthesis of Rifamycin S [PDF]
In the presence of sulfur dioxide and an acid promoter, (-)-(1E,3Z)-2-methyl-1-((1S)-1-phenyleth- oxy)penta-1,3-dien-3-yl isobutyrate reacts with (Z)-3-(trimethylsilyloxy)-pent-2-ene giving a silyl sulfinate intermediate that undergoes, in the presence ...
Vogel, P., Huang, X. G., Turks, M.
core +1 more source
Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins.
The Journal of Antibiotics, 1980 The biological properties of spiro-piperidyl-rifamycins, a new class of rifamycin antibiotics, are described. In these derivatives the positions 3 and 4 have been incorporated into an imidazolyl ring bearing a spiro-piperidyl group N substituted with linear and branched aliphatic chains. The in vitro antibacterial activity against Staphylococcus aureus
A, Sanfilippo +6 more
openaire +3 more sources